← Leaderboards
Ilya B Bezprozvanny
University Of Texas Sw Med Ctr/Dallas
$15,035,317
Attributed
$17,771,529
Total exposure
14
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.8M · FY2005–23$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$18,494,669 · 15
By mechanism
R01$12,886,906 · 7
RF1$2,964,535 · 1
R33$1,446,280 · 2
R56$698,240 · 1
R21$355,709 · 1
R03$102,999 · 2
Top collaborators
- Miao Zhang4 shared
- James S. Malter2 shared
- Ege T Kavalali1 shared
Others in their field
Top investigators on “Neurons”
- Hongkui Zeng · Allen Institute$106,358,289
- Eric Martin McDade · Washington University$94,632,845
- Ed Lein · Allen Institute$90,858,363
- Randall J Bateman · Washington University$65,841,935
- John Morris · Washington University$65,018,684
- Paul S. Aisen · Cognition Therapeutics, Inc.$58,570,460
Research focus
NeuronsSignal TransductionCalciumPathogenesisMouse ModelLaboratoriesGrantPlayProteinsSynapsesResearch StudyMolecularPublic Health RelevanceAffectCalcium SignalingAlzheimer&AposGeneticNerve DegenerationNeurodegenerative DisordersPolyglutamineCorpus Striatum StructureIn VivoItpr1 GeneImage
Grant awards (45)
Calcium dysregulation and vulnerability of entorhinal cortex neurons in Alzheimer's disease$730,800
R01 · FY2023 · AG · contact PI
ConProject-001$723,140
R33 · FY2021 · NS
Development of SK channel modulators as therapeutic agents for ataxia$723,140
R33 · FY2021 · NS
Calcium dysregulation and vulnerability of entorhinal cortex neurons in Alzheimer's disease$698,240
R56 · FY2021 · AG · contact PI
Deranged calcium signaling and polyglutamine expansion disorders$354,377
R01 · FY2020 · NS · contact PI
Deranged calcium signaling and polyglutamine expansion disorders$354,377
R01 · FY2019 · NS · contact PI
Development of SK channel modulators as therapeutic agents for ataxia$168,959
R21 · FY2019 · NS
Deranged calcium signaling and polyglutamine expansion disorders$354,377
R01 · FY2018 · NS · contact PI
Development of SK channel modulators as therapeutic agents for ataxia$186,750
R21 · FY2018 · NS
Calcium signaling and synaptic maintenance in Alzheimers disease$2,964,535
RF1 · FY2017 · AG · contact PI
Presenilins and neuronal calcium dyshomeostasis$459,113
R01 · FY2017 · NS · contact PI
Deranged calcium signaling and polyglutamine expansion disorders$354,377
R01 · FY2017 · NS · contact PI
Presenilins and neuronal calcium dyshomeostasis$459,113
R01 · FY2016 · NS · contact PI
Deranged calcium signaling and polyglutamine expansion disorders$353,739
R01 · FY2016 · NS · contact PI
Presenilins and neuronal calcium dyshomeostasis$459,113
R01 · FY2015 · NS · contact PI
Calcium channels as novel therapeutic targets for Huntingtons Disease$347,813
R01 · FY2015 · NS · contact PI
Presenilins and neuronal calcium dyshomeostasis$454,522
R01 · FY2014 · NS · contact PI
Calcium channels as novel therapeutic targets for Huntingtons Disease$344,334
R01 · FY2014 · NS · contact PI
Presenilins and neuronal calcium dyshomeostasis$459,113
R01 · FY2013 · NS · contact PI
Calcium channels as novel therapeutic targets for Huntingtons Disease$335,639
R01 · FY2013 · NS · contact PI
Calcium channels as novel therapeutic targets for Huntingtons Disease$347,356
R01 · FY2012 · NS · contact PI
Deranged calcium signaling and polyglutamine expansion disorders$336,569
R01 · FY2012 · NS · contact PI
Deranged calcium signaling and polyglutamine expansion disorders$336,569
R01 · FY2011 · NS · contact PI
Presenilins and neuronal calcium signaling$392,500
R01 · FY2010 · AG · contact PI
Deranged calcium signaling and polyglutamine expansion disorders$340,004
R01 · FY2010 · NS · contact PI
Presenilins and neuronal calcium signaling$392,500
R01 · FY2009 · AG · contact PI
Deranged calcium signaling and polyglutamine expansion disorders$343,438
R01 · FY2009 · NS · contact PI
Structure-function of inositol trisphosphate receptor$123,366
R01 · FY2009 · NS · contact PI
Deranged calcium signaling and polyglutamine expansion disorders$78,500
R01 · FY2009 · NS · contact PI
Deranged calcium signaling and polyglutamine expansion disorders$343,438
R01 · FY2008 · NS · contact PI
Structure-function of inositol trisphosphate receptor$337,145
R01 · FY2008 · NS · contact PI
2008 Calcium Signaling and Disease SGP Conference$40,000
R13 · FY2008 · NS · contact PI
HTS Screen for Small Molecule Inhibitors of Mint-PDZ Domain$24,999
R03 · FY2008 · MH · contact PI
Structure-function of inositol trisphosphate receptor$337,145
R01 · FY2007 · NS · contact PI
Structure-function of inositol trisphosphate receptor$347,214
R01 · FY2006 · NS · contact PI
Structure-function of inositol trisphosphate receptor$352,980
R01 · FY2005 · NS
Structure-function of inositol trisphosphate receptor$352,462
R01 · FY2004 · NS
Screen:Blockers of a CaV2.2-Mint-PDZ1 association (RMI)$78,000
R03 · FY2004 · NS
INTERACTIONS OF CALCIUM CHANNELS WITH ADAPTOR PROTEINS$390,000
R01 · FY2003 · NS
INTERACTIONS OF CALCIUM CHANNELS WITH ADAPTOR PROTEINS$390,000
R01 · FY2002 · NS
STRUCTURE/FUNCTION OF INOSITOL TRISPHOSPHATE RECEPTOR$268,197
R01 · FY2002 · NS
INTERACTIONS OF CALCIUM CHANNELS WITH ADAPTOR PROTEINS$376,274
R01 · FY2001 · NS
STRUCTURE/FUNCTION OF INOSITOL TRISPHOSPHATE RECEPTOR$260,473
R01 · FY2001 · NS
INTERACTIONS OF CALCIUM CHANNELS WITH ADAPTOR PROTEINS$362,008
R01 · FY2000 · NS
STRUCTURE/FUNCTION OF INOSITOL TRISPHOSPHATE RECEPTOR$257,961
R01 · FY2000 · NS